Rhythm Biosciences Ltd (ASX: RHY) Share Price and News
Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)
() Chart and Price Data
Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range
-
Days Range
-
Turnover
Fundamental Company Figures
Data provided by Morningstar.
Market Cap
$311.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
201.57 million
Earnings per share
-0.035
Dividend per share
N/A
Year To Date Return
65.71%
Earnings Yield
N/A
Franking
N/A
Rhythm Biosciences Limited (ASX: RHY) Latest News
What’s happening with the Rhythm (ASX:RHY) share price today?
Aaron Teboneras | February 11, 2021 2:02pm
Why the Rhythm (ASX:RHY) share price again reached a new all-time record today
Aaron Teboneras | January 20, 2021 12:24pm
Here’s why the Rhythm (ASX:RHY) share price hit an all-time high today
Aaron Teboneras | January 19, 2021 1:55pm
Rhythm Biosciences (ASX: RHY) share price soars 1300% in 6 months
Gretchen Kennedy | January 14, 2021 8:57am
Here’s why the Rhythm Bioscience (ASX:RHY) share price is up 15% to a record high
James Mickleboro | January 5, 2021 3:30pm
Here are 3 ASX small cap shares with exciting product launches in 2021
Eddy Sunarto | December 31, 2020 10:54am
Why the Rhythm Biosciences (ASX:RHY) share price jumped over 600% this year
Gretchen Kennedy | December 29, 2020 12:57pm
The Rhythm (ASX:RHY) share price is surging 5% higher today. Here’s why.
Aaron Teboneras | December 17, 2020 11:22am
Recent Stock Announcements
Price Sensitive OnlyAn announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Rhythm Biosciences Ltd (ASX: RHY)
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 26 Feb 2021 | $1.55 | $0.08 | 5.44% | 599,928 | $1.48 | $1.55 | $1.45 |
| 25 Feb 2021 | $1.47 | $0.02 | 1.38% | 620,381 | $1.46 | $1.52 | $1.45 |
| 24 Feb 2021 | $1.45 | $0.04 | 2.84% | 197,791 | $1.43 | $1.46 | $1.38 |
| 23 Feb 2021 | $1.41 | $-0.08 | -5.37% | 287,587 | $1.49 | $1.49 | $1.41 |
| 22 Feb 2021 | $1.49 | $0.05 | 3.47% | 238,478 | $1.48 | $1.49 | $1.46 |
| 19 Feb 2021 | $1.44 | $0.00 | 0.00% | 555,338 | $1.45 | $1.49 | $1.37 |
| 18 Feb 2021 | $1.44 | $0.06 | 4.35% | 726,339 | $1.40 | $1.54 | $1.40 |
| 17 Feb 2021 | $1.38 | $0.00 | 0.00% | 651,224 | $1.38 | $1.45 | $1.35 |
| 16 Feb 2021 | $1.38 | $0.03 | 2.24% | 642,836 | $1.34 | $1.50 | $1.34 |
| 15 Feb 2021 | $1.34 | $0.02 | 1.52% | 332,090 | $1.36 | $1.39 | $1.32 |
| 12 Feb 2021 | $1.32 | $-0.10 | -7.07% | 974,365 | $1.41 | $1.45 | $1.30 |
| 11 Feb 2021 | $1.42 | $-0.14 | -9.00% | 1,257,266 | $1.51 | $1.52 | $1.38 |
| 10 Feb 2021 | $1.56 | $0.25 | 19.08% | 3,371,491 | $1.34 | $1.60 | $1.34 |
| 09 Feb 2021 | $1.31 | $-0.01 | -0.76% | 260,861 | $1.35 | $1.35 | $1.29 |
| 08 Feb 2021 | $1.32 | $-0.02 | -1.49% | 894,760 | $1.35 | $1.36 | $1.25 |
| 05 Feb 2021 | $1.34 | $0.15 | 12.61% | 852,409 | $1.20 | $1.34 | $1.20 |
| 04 Feb 2021 | $1.19 | $-0.02 | -1.65% | 201,464 | $1.21 | $1.21 | $1.18 |
| 03 Feb 2021 | $1.21 | $0.00 | 0.00% | 116,167 | $1.23 | $1.23 | $1.19 |
| 02 Feb 2021 | $1.21 | $0.01 | 0.83% | 228,130 | $1.22 | $1.26 | $1.19 |
| 01 Feb 2021 | $1.20 | $0.02 | 1.70% | 786,128 | $1.14 | $1.23 | $1.08 |
| 29 Jan 2021 | $1.18 | $-0.15 | -11.36% | 1,006,652 | $1.32 | $1.36 | $1.17 |
| 28 Jan 2021 | $1.32 | $-0.04 | -2.93% | 605,619 | $1.37 | $1.37 | $1.26 |
Director Transactions
Data provided by Morningstar.
Show more
Directors & Management
Data provided by Morningstar.
Show more
Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Loumea Investment Pty Ltd | 10,000,000 | 8.63% |
| Ferndale Securities Pty Ltd | 6,500,000 | 5.61% |
| Northern Star Nominees Pty Ltd | 4,500,000 | 3.88% |
| Rojo Nero Capital Pty Ltd | 4,166,668 | 3.60% |
| Mrs Sarah Cameron | 3,008,334 | 2.60% |
| Jawaf Enterprises Pty Ltd | 3,000,000 | 2.59% |
| The Trust Company (Australia) Limited | 2,684,500 | 2.32% |
| Commonwealth Scientific & Industrial Research Organisation | 2,500,000 | 2.16% |
| Giokir Pty Ltd | 2,125,000 | 1.83% |
| Mr Hsien Michael Soo | 2,110,000 | 1.82% |
| Dc & Pc Holdings Pty Ltd | 2,055,000 | 1.77% |
| Ms Natalie Louise Patterson | 2,000,000 | 1.73% |
| Mowbrick Pte Ltd | 1,650,000 | 1.42% |
| Newfound Investments Pty Ltd | 1,500,000 | 1.29% |
| Shane Francis Tanner & Lisa Jane Wheeler | 1,500,000 | 1.29% |
| E&W Nominee Pty Ltd | 1,277,917 | 1.10% |
| Mr Daniel Eddington & Mrs Julie Eddington | 1,250,000 | 1.08% |
| Sindel Nominees Pty Ltd | 1,250,000 | 1.08% |
| Taycol Nominees Pty Ltd | 1,233,750 | 1.06% |
| Ardroy Securities Pty Ltd | 1,100,000 | 0.95% |